| Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 VC Foletta, MA Lim, J Soosairajah, AP Kelly, EG Stanley, M Shannon, ... The Journal of Cell Biology 162 (6), 1089-1098, 2003 | 382 | 2003 |
| Eukaryotic translation initiation factor 5 functions as a GTPase-activating protein S Das, R Ghosh, U Maitra Journal of Biological Chemistry 276 (9), 6720-6726, 2001 | 134 | 2001 |
| Specific interaction of eukaryotic translation initiation factor 5 (eIF5) with the β-subunit of eIF2 S Das, T Maiti, K Das, U Maitra Journal of Biological Chemistry 272 (50), 31712-31718, 1997 | 132 | 1997 |
| Mutational analysis of mammalian translation initiation factor 5 (eIF5): role of interaction between the β subunit of eIF2 and eIF5 in eIF5 function in vitro and in vivo S Das, U Maitra Molecular and Cellular Biology 20 (11), 3942-3950, 2000 | 86 | 2000 |
| Functional significance and mechanism of eIF5-promoted GTP hydrolysis in eukaryotic translation initiation S Das, U Maitra Prog Nucleic Acid Res Mol Biol 70, 207-231, 2001 | 70 | 2001 |
| Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication M Sorin, J Cano, S Das, S Mathew, X Wu, KP Davies, X Shi, SWG Cheng, ... PLoS pathogens 5 (6), e1000463, 2009 | 67 | 2009 |
| Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ... Journal of Biological Chemistry 295 (36), 12814-12821, 2020 | 58 | 2020 |
| Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6 A Biswas, S Mukherjee, S Das, D Shields, CW Chow, U Maitra Journal of biological chemistry 286 (4), 3129-3138, 2011 | 49 | 2011 |
| Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance S Das, J Cano, GV Kalpana Journal of biological chemistry 284 (30), 19903-19914, 2009 | 43 | 2009 |
| Chikungunya and arthritis: An overview R Kumar, S Ahmed, HA Parray, S Das Travel Medicine and Infectious Disease, 2021 | 33 | 2021 |
| Isolation and functional characterization of a temperature-sensitive mutant of the yeast Saccharomyces cerevisiae in translation initiation factor eIF5: an eIF5-dependent cell … T Maiti*, S Das*, U Maitra Gene 244 (1), 109-118, 2000 | 18 | 2000 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Kumar, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 2021 | 17 | 2021 |
| An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies S Boliar*, S Das*, M Bansal, BN Shukla, S Patil, T Shrivastava, S Samal, ... PloS one 10 (3), e0122443, 2015 | 16 | 2015 |
| Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail. S Samal*, S Das*, S Boliar, H Qureshi, T Shrivastava, N Kumar, ... Retrovirology 15 (1), 50, 2018 | 14 | 2018 |
| Reverse two-hybrid screening to analyze protein–protein interaction of HIV-1 viral and cellular proteins S Das, GV Kalpana Methods in Molecular Biology, 271-293, 2009 | 14 | 2009 |
| Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable … S Das, S Boliar, S Samal, S Ahmed, T Shrivastava, BN Shukla, ... Virology 510, 22-28, 2017 | 10 | 2017 |
| Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5) S Das, B Banerjee, M Hossain, M Thangamuniyandi, S Dasgupta, ... PLoS One 8 (7), e66581, 2013 | 10 | 2013 |
| Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 … S Das, S Boliar, N Mitra, S Samal, M Bansal, W C Koff, B K Chakrabarti Retrovirology 13 (81), 2016 | 9 | 2016 |
| A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern HA Parray, N Narayanan, S Garg, ZA Rizvi, T Shrivastava, S Kushwaha, ... PLoS Pathogens 18 (12), e1010994, 2022 | 8 | 2022 |
| The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41 R Perween, M PraveenKumar, T Shrivastava, HA Parray, V Singh, ... International Immunopharmacology 101, 108187, 2021 | 8 | 2021 |
